Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction.
Kimmel SE; Berlin JA; Reilly M; Jaskowiak J; Kishel L; Chittams J; Strom BL; Annals Of Internal Medicine, 2005, vol. 142, issue 3, p 157, ISSN 15393704. ISBN 15393704.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef